FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2321390295> ?p ?o ?g. }

• W2321390295 endingPage "973" @default.
• W2321390295 startingPage "967" @default.
• W2321390295 abstract "Many patients who have had upper gastrointestinal bleeding continue to take low-dose aspirin for cardiovascular prophylaxis or other non-steroidal antiinflammatory drugs (NSAIDs) for musculoskeletal pain. It is uncertain whether infection with Helicobacter pylori is a risk factor for bleeding in such patients.We studied patients with a history of upper gastrointestinal bleeding who were infected with H. pylori and who were taking low-dose aspirin or other NSAIDs. We evaluated whether eradication of the infection or omeprazole treatment was more effective in preventing recurrent bleeding. We recruited patients who presented with upper gastrointestinal bleeding that was confirmed by endoscopy. Their ulcers were healed by daily treatment with 20 mg of omeprazole for eight weeks or longer. Then, those who had been taking aspirin were given 80 mg of aspirin daily, and those who had been taking other NSAIDs were given 500 mg of naproxen twice daily for six months. The patients in each group were then randomly assigned separately to receive 20 mg of omeprazole daily for six months or one week of eradication therapy, consisting of 120 mg of bismuth subcitrate, 500 mg of tetracycline, and 400 mg of metronidazole, all given four times daily, followed by placebo for six months.We enrolled 400 patients (250 of whom were taking aspirin and 150 of whom were taking other NSAIDs). Among those taking aspirin, the probability of recurrent bleeding during the six-month period was 1.9 percent for patients who received eradication therapy and 0.9 percent for patients who received omeprazole (absolute difference, 1.0 percent; 95 percent confidence interval for the difference, -1.9 to 3.9 percent). Among users of other NSAIDs, the probability of recurrent bleeding was 18.8 percent for patients receiving eradication therapy and 4.4 percent for those treated with omeprazole (absolute difference, 14.4 percent; 95 percent confidence interval for the difference, 4.4 to 24.4 percent; P=0.005).Among patients with H. pylori infection and a history of upper gastrointestinal bleeding who are taking low-dose aspirin, the eradication of H. pylori is equivalent to treatment with omeprazole in preventing recurrent bleeding. Omeprazole is superior to the eradication of H. pylori in preventing recurrent bleeding in patients who are taking other NSAIDs." @default.
• W2321390295 created "2016-06-24" @default.
• W2321390295 creator A5005282582 @default.
• W2321390295 creator A5009554691 @default.
• W2321390295 creator A5014424225 @default.
• W2321390295 creator A5015440723 @default.
• W2321390295 creator A5020200326 @default.
• W2321390295 creator A5026614249 @default.
• W2321390295 creator A5043291688 @default.
• W2321390295 creator A5048726723 @default.
• W2321390295 creator A5049274840 @default.
• W2321390295 creator A5059972127 @default.
• W2321390295 creator A5060404344 @default.
• W2321390295 creator A5083337409 @default.
• W2321390295 date "2001-03-29" @default.
• W2321390295 modified "2023-10-14" @default.
• W2321390295 title "Preventing Recurrent Upper Gastrointestinal Bleeding in Patients with<i>Helicobacter pylori</i>Infection Who Are Taking Low-Dose Aspirin or Naproxen" @default.
• W2321390295 cites W1973505027 @default.
• W2321390295 cites W1982805851 @default.
• W2321390295 cites W1992492606 @default.
• W2321390295 cites W2007711753 @default.
• W2321390295 cites W2017818343 @default.
• W2321390295 cites W2033082059 @default.
• W2321390295 cites W2054883739 @default.
• W2321390295 cites W2059707463 @default.
• W2321390295 cites W2068648673 @default.
• W2321390295 cites W2073714032 @default.
• W2321390295 cites W2112264800 @default.
• W2321390295 cites W2143548707 @default.
• W2321390295 cites W2144643979 @default.
• W2321390295 cites W2157782064 @default.
• W2321390295 cites W2158310507 @default.
• W2321390295 cites W2313437711 @default.
• W2321390295 cites W2331085743 @default.
• W2321390295 cites W2333044470 @default.
• W2321390295 doi "https://doi.org/10.1056/nejm200103293441304" @default.
• W2321390295 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11274623" @default.
• W2321390295 hasPublicationYear "2001" @default.
• W2321390295 type Work @default.
• W2321390295 sameAs 2321390295 @default.
• W2321390295 citedByCount "605" @default.
• W2321390295 countsByYear W23213902952012 @default.
• W2321390295 countsByYear W23213902952013 @default.
• W2321390295 countsByYear W23213902952014 @default.
• W2321390295 countsByYear W23213902952015 @default.
• W2321390295 countsByYear W23213902952016 @default.
• W2321390295 countsByYear W23213902952017 @default.
• W2321390295 countsByYear W23213902952018 @default.
• W2321390295 countsByYear W23213902952019 @default.
• W2321390295 countsByYear W23213902952020 @default.
• W2321390295 countsByYear W23213902952021 @default.
• W2321390295 countsByYear W23213902952022 @default.
• W2321390295 countsByYear W23213902952023 @default.
• W2321390295 crossrefType "journal-article" @default.
• W2321390295 hasAuthorship W2321390295A5005282582 @default.
• W2321390295 hasAuthorship W2321390295A5009554691 @default.
• W2321390295 hasAuthorship W2321390295A5014424225 @default.
• W2321390295 hasAuthorship W2321390295A5015440723 @default.
• W2321390295 hasAuthorship W2321390295A5020200326 @default.
• W2321390295 hasAuthorship W2321390295A5026614249 @default.
• W2321390295 hasAuthorship W2321390295A5043291688 @default.
• W2321390295 hasAuthorship W2321390295A5048726723 @default.
• W2321390295 hasAuthorship W2321390295A5049274840 @default.
• W2321390295 hasAuthorship W2321390295A5059972127 @default.
• W2321390295 hasAuthorship W2321390295A5060404344 @default.
• W2321390295 hasAuthorship W2321390295A5083337409 @default.
• W2321390295 hasBestOaLocation W23213902951 @default.
• W2321390295 hasConcept C126322002 @default.
• W2321390295 hasConcept C141071460 @default.
• W2321390295 hasConcept C142724271 @default.
• W2321390295 hasConcept C204787440 @default.
• W2321390295 hasConcept C27081682 @default.
• W2321390295 hasConcept C2776345487 @default.
• W2321390295 hasConcept C2776409635 @default.
• W2321390295 hasConcept C2777396551 @default.
• W2321390295 hasConcept C2777498785 @default.
• W2321390295 hasConcept C2777628954 @default.
• W2321390295 hasConcept C2778080469 @default.
• W2321390295 hasConcept C2778451229 @default.
• W2321390295 hasConcept C501593827 @default.
• W2321390295 hasConcept C71924100 @default.
• W2321390295 hasConcept C86803240 @default.
• W2321390295 hasConcept C89423630 @default.
• W2321390295 hasConcept C90924648 @default.
• W2321390295 hasConceptScore W2321390295C126322002 @default.
• W2321390295 hasConceptScore W2321390295C141071460 @default.
• W2321390295 hasConceptScore W2321390295C142724271 @default.
• W2321390295 hasConceptScore W2321390295C204787440 @default.
• W2321390295 hasConceptScore W2321390295C27081682 @default.
• W2321390295 hasConceptScore W2321390295C2776345487 @default.
• W2321390295 hasConceptScore W2321390295C2776409635 @default.
• W2321390295 hasConceptScore W2321390295C2777396551 @default.
• W2321390295 hasConceptScore W2321390295C2777498785 @default.
• W2321390295 hasConceptScore W2321390295C2777628954 @default.
• W2321390295 hasConceptScore W2321390295C2778080469 @default.
• W2321390295 hasConceptScore W2321390295C2778451229 @default.
• W2321390295 hasConceptScore W2321390295C501593827 @default.
• W2321390295 hasConceptScore W2321390295C71924100 @default.

• next